Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

3.57
-0.0200-0.56%
Post-market: 3.54-0.0299-0.84%19:47 EDT
Volume:2.46M
Turnover:8.87M
Market Cap:644.42M
PE:-3.29
High:3.71
Open:3.54
Low:3.48
Close:3.59
52wk High:6.94
52wk Low:2.67
Shares:180.51M
Float Shares:116.00M
Volume Ratio:1.03
T/O Rate:2.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0853
EPS(LYR):-1.3521
ROE:-373.29%
ROA:-46.52%
PB:16.19
PE(LYR):-2.64

Loading ...

Jun 16, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Major Issues Report

8-K/A [Amend] - Current report
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2022

Major Issues Report

8-K - Current report